酸交联基基基基基基膜:一种有希望的生物材料,用于药物输送
Vishwajeet Sampatrao Ghorpade1, Kailas Krishnat Mali2, Remeth Jacky Dias3
1Department of Pharmaceutics, Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad 415539, Maharashtra, India.
International journal of biological macromolecules
|November 1, 2024
概括
与酸交叉连接的基乙烯 (Hydroxyethyl tamarind gum) 水凝薄膜显示出作为可生物相容的伤口愈合材料,可用于控制药物输送. 这些膜表现出良好的机械性能,胀和药物释放能力.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 茄子是一种天然的多糖,需要修改以获得增强的生物材料特性.
- 基乙基化改善了塔玛林的可溶性,胀和交叉连接潜力.
- 开发新的水凝膜,以有效和安全的药物输送至关重要.
研究的目的:
- 为了合成和表征酸交联氧乙塔玛林水凝膜.
- 评估片作为药物输送的生物材料的潜力,特别是用于伤口愈合的应用.
- 为了研究不同度的基乙基化棕糖和酸对薄膜特性的影响.
主要方法:
- 泰玛林的基乙化,随后由酸诱导的交叉链接.
- 使用仪器技术进行表征,以确认交叉连接和功能组.
- 评估机械特性,胀,药物加载/释放动力学,抗菌活性,血液相容性和体外伤口愈合潜力.
主要成果:
- 成功合成了具有改进性质的基乙基化麻 (HETG).
- 酸的交叉连接通过结形成和碳素含量分析得到证实.
- 可调整的机械强度,胀和药物负载,通过调整HETG和酸度来实现.
- 通过非Fickian扩散,控制释放一种水溶性药物 (24小时内80.87-99.70%).
- 优化的膜显示了抗菌活性,血红相容性,并支持细胞生长,表明生物相容性.
结论:
- 酸交叉链接的基乙基塔玛林水凝薄膜是药物输送的有希望的生物相容材料.
- 开发的水凝膜由于其特性和生物活性,具有愈应用的潜力.
- 需要进一步的体内研究来验证这些薄膜的治疗潜力.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
01:11Oral Drug Delivery Systems: Delayed-Release Systems
228
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
228